PRESS RELEASE – Constellation Kidney Group Acquires the NephroCare Clinical System
RICHMOND, VA , January 8 , 2020 – The Constellation Kidney Group, an international market leader in dialysis software solutions has acquired the assets of NephroCare software from Fresenius Medical Care Canada Inc.
Fresenius Medical Care Canada Inc. (FMCC) through it’s NephroCare software is a leading provider of Renal Electronic Health Record Solutions in the Canadian dialysis market. FMCC is headquartered in Richmond Hill, Ontario, CA.
“Our mission is to bring the best renal software companies in the world together to better assist health care providers in managing end-stage-renal disease and to push renal care forward. With NephroCare we add to our broad base of Canadian customers and add great minds and innovative technology to our team.” said Paul Benson, General Manager of the Constellation Kidney Group.
“Constellation is a great match for our NephroCare team. Their focus on long-term stability, customer engagement and product development will serve our employees and customers well ” said Sean O’Connor, President for Fresenius Medical Care Canada Inc.
About The Constellation Kidney Group:
The Constellation Kidney Group offers dialysis specific software solutions to healthcare providers in the US, United Kingdom, Canada, Ireland, Australia, and New Zealand . The Constellation Kidney Group is part of Constellation Software Inc., an international software company traded publicly on the Toronto Stock Exchange. Constellation Software Inc., acquires, manages, and builds software businesses which provide specialized, mission-critical software solutions.